BPTF inhibitor increases gastric cancer response to Erlotinib by epigenetically regulating c-MYC/PLCG1/pErk axis [ChIP-seq]
Ontology highlight
ABSTRACT: BPTF inhibitor increases gastric cancer response to Erlotinib by epigenetically regulating c-MYC/PLCG1/pErk axis [ChIP-seq]
PROVIDER: PRJNA823561 | ENA |
REPOSITORIES: ENA
ACCESS DATA